Vaishali S. Mankad

Statistics

Publications

Citations

479

H-Index

Active since

2007

Affiliations

AstraZeneca (United States)(Current)

AstraZeneca (Sweden)

AstraZeneca (United Kingdom)

Ben-Gurion University of the Negev

AstraZeneca (Spain)

Vaishali S. Mankad is an author at AstraZeneca (United States) specializing in pediatrics, pediatric clinical pharmacology, and pediatric pharmacotherapy.

Publications per year

2007–2025

Publications

Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps

Brian J. Lipworth, Joseph K. Han, Martin Desrosiers et al. · New England Journal of Medicine · 2025 · 145 citations · Full text

Medicine, Otolaryngology, Pharmacotherapy +16

Clinical Characteristics of Peanut-Allergic Children: Recent Changes

Todd D. Green, Virginia S. LaBelle, Pamela H. Steele et al. · PEDIATRICS · 2007 · 76 citations

Life Sciences, Immunology, Pediatrics +12

Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials

Bahar Ahani, Kevin M. Tuffy, Anastasia A. Aksyuk et al. · Nature Communications · 2023 · 76 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +11

Infants Receiving a Single Dose of Nirsevimab to Prevent RSV Do Not Have Evidence of Enhanced Disease in Their Second RSV Season

Ron Dagan, Laura L. Hammitt, Beatriz Seoane Núñez et al. · Journal of the Pediatric Infectious Diseases Society · 2024 · 47 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +13

Safety of open food challenges in the office setting

Vaishali S. Mankad, Larry W. Williams, Laurie A. Lee et al. · Annals of Allergy Asthma & Immunology · 2008 · 37 citations

Agriculture, Food Science, Nutrition +11

1–5 of 9